How to buy Allena Pharmaceuticals stock

Allena Pharmaceuticals, Inc is a biotechnology business based in the US. Allena Pharmaceuticals shares (ALNA) are listed on the NASDAQ and all prices are listed in US Dollars. Allena Pharmaceuticals employs 29 staff and has a market cap (total outstanding shares value) of USD$57.2 million.

How to buy shares in Allena Pharmaceuticals

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Allena Pharmaceuticals. Find the stock by name or ticker symbol: ALNA. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Allena Pharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Allena Pharmaceuticals, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Allena Pharmaceuticals. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Allena Pharmaceuticals share price

Use our graph to track the performance of ALNA stocks over time.

Allena Pharmaceuticals shares at a glance

• Key figures

Information last updated 2020-10-20.

52-week range	USD$0.525 - USD$6.3
50-day moving average	USD$1.379
200-day moving average	USD$1.5547
Wall St. target price	USD$7.83
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-2.009

Buy Allena Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Allena Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Allena Pharmaceuticals, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Allena Pharmaceuticals financials

Gross profit TTM	USD$0
Return on assets TTM	-57.61%
Return on equity TTM	-139.91%
Profit margin	0%
Book value	$0.57
Market capitalisation	USD$57.2 million

TTM: trailing 12 months

Shorting Allena Pharmaceuticals shares

There are currently 1.1 million Allena Pharmaceuticals shares held short by investors – that's known as Allena Pharmaceuticals's "short interest". This figure is 15.9% down from 1.3 million last month.

There are a few different ways that this level of interest in shorting Allena Pharmaceuticals shares can be evaluated.

Allena Pharmaceuticals's "short interest ratio" (SIR)

Allena Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Allena Pharmaceuticals shares currently shorted divided by the average quantity of Allena Pharmaceuticals shares traded daily (recently around 2.1 million). Allena Pharmaceuticals's SIR currently stands at 0.51. In other words for every 100,000 Allena Pharmaceuticals shares traded daily on the market, roughly 510 shares are currently held short.

However Allena Pharmaceuticals's short interest can also be evaluated against the total number of Allena Pharmaceuticals shares, or, against the total number of tradable Allena Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Allena Pharmaceuticals's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Allena Pharmaceuticals shares in existence, roughly 30 shares are currently held short) or 0.0345% of the tradable shares (for every 100,000 tradable Allena Pharmaceuticals shares, roughly 35 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Allena Pharmaceuticals.

Find out more about how you can short Allena Pharmaceuticals stock.

Allena Pharmaceuticals share dividends

We're not expecting Allena Pharmaceuticals to pay a dividend over the next 12 months.

Allena Pharmaceuticals share price volatility

Over the last 12 months, Allena Pharmaceuticals's shares have ranged in value from as little as $0.525 up to $6.3. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Allena Pharmaceuticals's is 2.5477. This would suggest that Allena Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Allena Pharmaceuticals overview

Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, engages in the development and commercialization of oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States and internationally. The company's lead product candidate is reloxaliase, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria, a metabolic disorder commonly associated with kidney stones in adults. It also develops ALLN-346 for patients with hyperuricemia and moderate to severe chronic kidney diseases. The company was founded in 2011 and is headquartered in Newton, Massachusetts.

Frequently asked questions

• What percentage of Allena Pharmaceuticals is owned by insiders or institutions?

  Currently 10.155% of Allena Pharmaceuticals shares are held by insiders and 61.649% by institutions.

• How many people work for Allena Pharmaceuticals?

  Latest data suggests 29 work at Allena Pharmaceuticals.

• When does the fiscal year end for Allena Pharmaceuticals?

  Allena Pharmaceuticals's fiscal year ends in December.

• Where is Allena Pharmaceuticals based?

  Allena Pharmaceuticals's address is: One Newton Executive Park, Newton, MA, United States, 02462

• What is Allena Pharmaceuticals's ISIN number?

  Allena Pharmaceuticals's international securities identification number is: US0181191075

• What is Allena Pharmaceuticals's CUSIP number?

  Allena Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 018119107